Edwards Lifesciences Corp (EW)
Edwards Lifesciences Corp (EW) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 1,741 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1,243 | 1,266 | 1,330 | 1,386 | 1,354 | 1,386 | 1,413 | 1,532 | 1,553 | 1,570 | 1,649 | 1,741 | 6,512 | |
| 272 | 251 | 289 | 298 | 263 | 292 | 302 | 343 | 345 | 341 | 359 | 391 | 1,436 | |
| 971 | 1,015 | 1,041 | 1,088 | 1,092 | 1,094 | 1,111 | 1,190 | 1,210 | 1,229 | 1,289 | 1,350 | 5,078 | |
| 243 | 242 | 257 | 273 | 253 | 271 | 255 | 276 | 281 | 268 | 263 | 279 | 1,091 | |
| 440 | 479 | 490 | 451 | 421 | 492 | 466 | 502 | 515 | 603 | 522 | – | – | |
| 625 | 659 | 685 | 723 | 741 | 781 | 716 | 759 | 785 | 859 | 775 | 831 | 3,249 | |
| 347 | 357 | 356 | 365 | 351 | 313 | 395 | 431 | 425 | 370 | 515 | 520 | 1,830 | |
| – | 28 | – | – | – | – | – | – | – | – | – | – | – | |
| 388 | 367 | 371 | 387 | 403 | 390 | 434 | 400 | 348 | 90 | 459 | 520 | 1,418 | |
| 53 | 34 | 46 | 20 | 41 | 45 | 70 | 64 | 56 | 26 | 78 | 278 | 439 | |
| 385 | 370 | 352 | 364 | 3,071 | 386 | 358 | 330 | 291 | 91 | 381 | 242 | 1,005 | |
| 425 | 404 | 410 | 426 | 429 | 484 | 471 | 400 | 388 | 133 | 500 | 520 | 1,540 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.